PT Medikaloka Hermina Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024 - Marketscreener.com
| HEAL Stock | IDR 1,460 15.00 1.02% |
About 62% of Medikaloka Hermina's investor base is looking to short. The analysis of current outlook of investing in Medikaloka Hermina PT suggests that many traders are alarmed regarding Medikaloka Hermina's prospects. Medikaloka Hermina's investing sentiment shows overall attitude of investors towards Medikaloka Hermina PT.
Medikaloka |
PT Medikaloka Hermina Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024 Marketscreener.com
Read at news.google.com
 |
Medikaloka Hermina Fundamental Analysis
We analyze Medikaloka Hermina's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medikaloka Hermina using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medikaloka Hermina based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Insiders
Shares Owned By Insiders Comparative Analysis
Medikaloka Hermina is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Medikaloka Hermina Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Medikaloka Hermina stock to make a market-neutral strategy. Peer analysis of Medikaloka Hermina could also be used in its relative valuation, which is a method of valuing Medikaloka Hermina by comparing valuation metrics with similar companies.
Peers
Medikaloka Hermina Related Equities
| SILO | Siloam International | 1.31 | ||||
| AMRT | Sumber Alfaria | 1.97 | ||||
| MIKA | Mitra Keluarga | 2.27 | ||||
| EMTK | Elang Mahkota | 4.03 |
Other Information on Investing in Medikaloka Stock
Medikaloka Hermina financial ratios help investors to determine whether Medikaloka Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medikaloka with respect to the benefits of owning Medikaloka Hermina security.